Health Condition 1: G43- Migraine
Conditions
Interventions
Intervention1: Intermittent theta burst repetitive transcranial magnetic stimulation: Active group: active coils using stimulus intensity of 80% of MT, with Frequency-50 Hz, burst frequency-5Hz, deliv
Sponsors
Sujita Singh
Ajay Kumar
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with migraine, diagnosed according to the International Classification of Headache Disorders (ICHD-3rd edition) 2.Age between 18-60 years 3.Sex: all gender 4.Written informed consent for the study obtained from the participants. 5.With or without any prophylactic treatment.
Exclusion criteria
Exclusion criteria: 1.Any other type of chronic or recurrent headache such as diagnosed as sinusitis, refractive errors, cervical spondylosis, and neurological conditions. 2.Neuropsychiatry disorders Organic brain conditions, History of severe head injury, epilepsy, space occupying lesion, trigeminal neuralgia, hydrocephalous, meningitis, and other pain conditions. 3.Otherwise physically healthy conditions 4.Psychogenic pain, tension headache, Somatoform pain disorder 5.Use of botulinum toxin in head or neck region in last 6 months. 6.Active phase of any major Psychiatry illness (Schizophrenia, Bipolar disorder), substance use disorder (except moderate tea and nicotine use). 7.Active phase of depression 8.Confirmed Pregnancy • Having cochlear implant, cardiac pacemaker and metal body implanted in the body.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduction in migraine days, frequency, severity, and duration in migraine in chronic migraine patientTimepoint: patient is assessed for severity, intensity, and duration of migraine by MIDAS, Headache Impact Test-6 (HIT-6)and migraine dairy at 4th, 6th, and 12th week of post-intervention period | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the improvement from the bassline in intensity of migraine attacks and burden of drugs used for the episode of migraine in the active rTMS and sham rTMS group.Timepoint: 4th,6th and 12th week of post intervention period | — |
Countries
India
Contacts
Public ContactDr Sujita Singh
AIIMS, Raipur
Outcome results
None listed